GABELLI FUNDS LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 65 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 14.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$7,000
+40.0%
10,4110.0%0.00%
Q3 2020$5,000
-66.7%
10,411
-49.0%
0.00%
Q2 2020$15,000
+50.0%
20,411
+96.1%
0.00%
Q1 2020$10,000
-52.4%
10,4110.0%0.00%
Q4 2019$21,000
-30.0%
10,4110.0%0.00%
Q3 2019$30,000
-62.5%
10,4110.0%0.00%
-100.0%
Q2 2019$80,00010,4110.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 1,044,783$34,770,0004.41%
1492 Capital Management LLC 101,582$3,381,0001.96%
Tekla Capital Management LLC 680,862$22,659,0000.90%
ARBOR CAPITAL MANAGEMENT LLC 186,495$6,207,0000.74%
HUSSMAN STRATEGIC ADVISORS, INC. 210,000$6,989,0000.73%
Pergamon Offshore Advisors, L.P. 18,711$623,0000.60%
Partner Investment Management, L.P. 11,594$386,0000.58%
Penn Capital Management Company, LLC 426,937$14,208,0000.56%
HighPoint Advisor Group LLC 10,609$360,0000.55%
EAGLE ASSET MANAGEMENT INC 2,461,980$81,934,0000.47%
View complete list of ACORDA THERAPEUTICS INC shareholders